Case report
Acyclovir-induced renal failure: Clinical course and histology

https://doi.org/10.1016/0002-9343(88)90313-0Get rights and content

Abstract

Four patients with a chronic fatigue syndrome experienced five episodes of acute renal insufficiency associated with high-dose (500 mg/m2) intravenous acyclovir administered intravenously as one-hour infusions. Nephrotoxicity developed despite precautions to avoid volume contraction. Examination of the urinary sediment of three patients by polarizing microscopy showed birefringent needle-shaped crystals within leukocytes. In the most severely affected patient, a serum creatinine concentration of 8.6 mg/dl developed and the patient underwent percutaneous renal biopsy that revealed foci of interstitial inflammation without tubular necrosis. Urine, blood, and renal tissue levels of acyclovir were high. One patient was rechallenged with low-dose intravenous acyclovir and the four patients later received oral acyclovir, all without adverse effect. The combined data from these patients support crystalluria and obstructive nephropathy as a mechanism of acyclovir-induced renal failure in humans. This experience emphasizes the importance of maintaining adequate hydration during high-dose acyclovir therapy.

References (16)

There are more references available in the full text version of this article.

Cited by (186)

  • Acyclovir dosing in herpes encephalitis: A scoping review

    2024, Journal of the American Pharmacists Association
  • Validation of antiviral potential of herbal ethnomedicine

    2022, Evidence-Based Validation of Herbal Medicine: Translational Research on Botanicals
  • A diagnostician's field guide to crystalline nephropathies

    2020, Seminars in Diagnostic Pathology
    Citation Excerpt :

    Its association with crystal formation in the kidney is reported in the setting of rapid intravenous infusion at high dosages. Acyclovir crystals are birefringent under polarized light, needle-shaped and can be seen in renal tubules and urine.58 Recovery of renal function is expected in most patients with one report showing recovery of renal function to baseline in an average of 6.5 days after discontinuation of acyclovir.58

  • Nephrotoxicity of Antimicrobials and Antibiotics

    2020, Advances in Chronic Kidney Disease
  • Medication-Induced Kidney Injury for the Primary Care Pediatrician

    2023, Current Treatment Options in Pediatrics
View all citing articles on Scopus

This work was supported in part by a grant from the Burroughs Wellcome Company.

View full text